期刊文献+

糖尿病基因靶向治疗研究进展 被引量:1

原文传递
导出
摘要 糖尿病是由遗传和环境因素共同参与并相互作用而引起的因胰岛素分泌缺陷或作用障碍所致的以高血糖为基本特征的多因子进展性复杂病,目前尚无法根治。因此,有必要探寻新的治疗途径。而基因靶向治疗正以其特有的优越性日益受到关注。
作者 宋滇平 李斌
出处 《中华临床医师杂志(电子版)》 CAS 2010年第9期5-7,共3页 Chinese Journal of Clinicians(Electronic Edition)
  • 相关文献

参考文献1

二级参考文献36

  • 1[1]Dieterle C,Brendel MD,Seissler J,Eckhard M,Bretzel RG,Landgraf R.[Therapy of diabetes mellitus.Pancreas transplantation,islet transplantation,stem cell and gene therapy] Internist (Bed) 2006; 47:489-496,498-501
  • 2[2]Samson SL,Chan L.Gene therapy for diabetes:reinventing the islet.Trends Endocrinol Metab 2006; 17:92-100
  • 3[3]Shapiro AM,Lakey JR,Ryan EA,Korbutt GS,Toth E,Warnock GL,Kneteman NM,Rajotte RV.Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.N Engl J Med 2000; 343:230-238
  • 4[4]Lau J,Mattsson G,Carlsson C,Nyqvist D,Kohler M,Berggren PO,Jansson L,Carlsson PO.Implantation sitedependent dysfunction of transplanted pancreatic islets.Diabetes 2007; 56:1544-1550
  • 5[5]Li M,Inaba M,Guo KQ,Hisha H,Abraham NG,Ikehara S.Treatment of streptozotocin-induced diabetes mellitus in mice by intra-bone marrow bone marrow transplantation plus portal vein injection of beta cells induced from bone marrow cells.Int J Hematol 2007; 86:438-445
  • 6[6]-9 Brenner S,Ryser MF,Whiting-Theobald NL,Gentsch M,Linton GF,Malech HL.The late dividing population of gamma-retroviral vector transduced human mobilized peripheral blood progenitor cells contributes most to genemarked cell engraftment in nonobese diabetic/severe combined immunodeficient mice.Stem Cells 2007; 25:1807-1813
  • 7[10]Timper K,Seboek D,Eberhardt M,Linscheid P,Christ Crain M,Keller U,Muller B,Zulewski H.Human adipose tissue-derived mesenchymal stem cells differentiate into insulin,somatostatin,and glucagon expressing cells.Biochem Biophys Res Commun 2006; 341:1135-1140
  • 8[11]Fukushima M,Hattori Y,Tsukada H,Koga K,Kajiwara E,Kawano K,Kobayashi T,Kamata K,Maitani Y.Adiponectin gene therapy of streptozotocin-induced diabetic mice using hydrodynamic injection.J Gene Med 2007; 9:976-985
  • 9[12]Yoo HS,Mazda O,Lee HY,Kim JC,Kwon SM,Lee JE,Kwon IC,Jeong H,Jeong YS,Jeong SY.In vivo gene therapy of type I diabetic mellitus using a cationic emulsion containing an Epstein Barr Virus (EBV) based plasmid vector.J Control Release 2006; 112:139-144
  • 10[13]Lu YC,Sternini C,Rozengurt E,Zhukova E.Release of transgenic human insulin from gastric g cells:a novel approach for the amelioration of diabetes.Endocrinology 2005; 146:2610-2619

共引文献2

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部